Wuling San ameliorates renal fibrosis through modulating S1PR2 activation and suppressing the RhoA/ROCK pathway in adenine-induced chronic kidney disease.
- DOI
- 10.1016/j.jep.2026.121675
- Published
- 2026 Aug 10
- Container
- Journal of ethnopharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jep.2026.121675,
title = {Wuling San ameliorates renal fibrosis through modulating S1PR2 activation and suppressing the RhoA/ROCK pathway in adenine-induced chronic kidney disease.},
author = {Zeng Z and Zhou J and Jiang H and Liao Y and Zhao X and Cao Y and Lao B and Zhou Y and Zhou J},
year = {2026},
journal = {Journal of ethnopharmacology},
doi = {10.1016/j.jep.2026.121675},
url = {https://doi.org/10.1016/j.jep.2026.121675}
}RIS
TY - JOUR TI - Wuling San ameliorates renal fibrosis through modulating S1PR2 activation and suppressing the RhoA/ROCK pathway in adenine-induced chronic kidney disease. AU - Zeng Z AU - Zhou J AU - Jiang H AU - Liao Y AU - Zhao X AU - Cao Y AU - Lao B AU - Zhou Y AU - Zhou J PY - 2026 JO - Journal of ethnopharmacology DO - 10.1016/j.jep.2026.121675 UR - https://doi.org/10.1016/j.jep.2026.121675 ER -
APA
Z, Z., J, Z., H, J., Y, L., X, Z., Y, C., B, L., Y, Z., & J, Z. (2026). Wuling San ameliorates renal fibrosis through modulating S1PR2 activation and suppressing the RhoA/ROCK pathway in adenine-induced chronic kidney disease.. Journal of ethnopharmacology. https://doi.org/10.1016/j.jep.2026.121675
Source records
- pubmed · retrieved 2026-09-26T00:34:51.758Z